Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
ReNew
RNW
$2.27B
| $34.1K | ﹤0.01% |
+5,468
| New | +$32.8K |
|
4177
Oramed Pharmaceuticals
ORMP
$167M
| $34K | ﹤0.01% |
13,239
| – | – |
|
4178
Stereotaxis
STXS
$126M
| $33.7K | ﹤0.01% |
+18,541
| New | +$41.6K |
|
|
DNMR
4179
DELISTED
Danimer Scientific, Inc.
DNMR
| $33.6K | ﹤0.01% |
1,392
-138
| -9% | -$4.29K |
|
|
IVAC
4180
DELISTED
Intevac Inc
IVAC
| $33.5K | ﹤0.01% |
8,667
-13,649
| -61% | -$53.8K |
|
|
ASRT
4181
DELISTED
Assertio
ASRT
| $33.4K | ﹤0.01% |
1,794
-2,842
| -61% | -$42.2K |
|
4182
CALL
Cigna
CI
$73.7B
| $33.1K | ﹤0.01% |
+100
| New | +$34.5K |
|
4183
Intuitive Machines
LUNR
$1.98B
| $32.8K | ﹤0.01% |
+9,947
| New | +$49.4K |
|
4184
InnovAge Holding
INNV
$1.54B
| $32.7K | ﹤0.01% |
6,585
-6,648
| -50% | -$28.9K |
|
4185
Telecom Argentina
TEO
$6.03B
| $32.5K | ﹤0.01% |
4,500
| – | – |
|
4186
Alto Neuroscience
ANRO
$1.05B
| $32.5K | ﹤0.01% |
3,043
-2,861
| -48% | -$37.2K |
|
4187
Sonida Senior Living
SNDA
$1.91B
| $32.3K | ﹤0.01% |
1,175
-1,590
| -58% | -$46.3K |
|
|
TWOU
4188
DELISTED
2U Inc
TWOU
| $32.1K | ﹤0.01% |
6,265
+942
| +18% | +$8.16K |
|
|
RAPT
4189
DELISTED
RAPT Therapeutics
RAPT
| $32.1K | ﹤0.01% |
1,317
-10,260
| -89% | -$474K |
|
|
SPYM
4190
State Street SPDR Portfolio S&P 500 ETF
SPYM
$162B
| $32K | ﹤0.01% |
500
| – | – |
|
|
CRESY
4191
Cresud
CRESY
$795M
| $31.8K | ﹤0.01% |
3,899
| – | – |
|
4192
Skillsoft
SKIL
$63.7M
| $31.7K | ﹤0.01% |
2,293
-1,565
| -41% | -$13.9K |
|
4193
Immunocore
IMCR
$1.72B
| $31.7K | ﹤0.01% |
935
-6,813
| -88% | -$347K |
|
4194
CervoMed
CRVO
$23.9M
| $31.3K | ﹤0.01% |
+1,829
| New | +$40K |
|
4195
Vermilion Energy
VET
$1.82B
| $31.3K | ﹤0.01% |
2,840
-27,052
| -90% | -$321K |
|
4196
Hudbay
HBM
$10.1B
| $31.1K | ﹤0.01% |
3,439
-68,711
| -95% | -$596K |
|
4197
Better Home & Finance Holding
BETR
$443M
| $31K | ﹤0.01% |
1,351
| – | – |
|
4198
DLH Holdings
DLHC
$70.7M
| $31K | ﹤0.01% |
2,934
-5,947
| -67% | -$67.1K |
|
4199
C&F Financial
CFFI
$268M
| $30.8K | ﹤0.01% |
640
-1,583
| -71% | -$69K |
|
4200
UWM Holdings
UWMC
$617M
| $30.8K | ﹤0.01% |
4,443
-15,486
| -78% | -$106K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.